Abstract:Abstract Background Early provision of palliative care, at least 3–4 months before death, can improve patient quality of life and reduce burdensome treatments and financial costs. However, there is wide variation in the duration of palliative care received before death reported across the research literature. This study aims to determine the duration of time from initiation of palliative care to death for adults receiving palliative care across the international literature. Methods We conducted a systematic review and meta-analysis that was registered with PROSPERO (CRD42018094718). Six databases were searched for articles published between Jan 1, 2013, and Dec 31, 2018: MEDLINE, Embase, CINAHL, Global Health, Web of Science and The Cochrane Library, as well undertaking citation list searches. Following PRISMA guidelines, articles were screened using inclusion (any study design reporting duration from initiation to death in adults palliative care services) and exclusion (paediatric/non-English language studies, trials influencing the timing of palliative care) criteria. Quality appraisal was completed using Hawker’s criteria and the main outcome was the duration of palliative care (median/mean days from initiation to death). Results One hundred sixty-nine studies from 23 countries were included, involving 11,996,479 patients. Prior to death, the median duration from initiation of palliative care to death was 18.9 days (IQR 0.1), weighted by the number of participants. Significant differences between duration were found by disease type (15 days for cancer vs 6 days for non-cancer conditions), service type (19 days for specialist palliative care unit, 20 days for community/home care, and 6 days for general hospital ward) and development index of countries (18.91 days for very high development vs 34 days for all other levels of development). Forty-three per cent of studies were rated as ‘good’ quality. Limitations include a preponderance of data from high-income countries, with unclear implications for low- and middle-income countries. Conclusions Duration of palliative care is much shorter than the 3–4 months of input by a multidisciplinary team necessary in order for the full benefits of palliative care to be realised. Furthermore, the findings highlight inequity in access across patient, service and country characteristics. We welcome more consistent terminology and methodology in the assessment of duration of palliative care from all countries, alongside increased reporting from less-developed settings, to inform benchmarking, service evaluation and quality improvement.

Palliative care interventions and end-of-life care for patients with metastatic breast cancer: a multicentre analysis

Multicentre analysis of intensity of care at the end-of-life in patients with advanced cancer, combining health administrative data with hospital records: variations in practice call for routine quality evaluation

The Impact of Palliative Care Consultation on Aggressive Medical Interventions in End-of-life Among Patients with Metastatic Breast Cancer: Insights from the U.S. National Patient Sample

Specialist Palliative Care Use and End-of-Life Care in Patients with Metastatic Cancer

The use of in-hospital medical care for patients with metastasized colon, bronchus, or lung cancer

Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer

Timing, Costs, and Survival Outcome of Specialty Palliative Care in Medicare Beneficiaries with Metastatic Non-Small-Cell Lung Cancer

Early palliative care for patients with metastatic non-small-cell lung cancer.

Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer

Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study

Utilization of medical interventions in hospitalized Mexican adults with cancer at the end of life in a referral hospital: The importance of early palliative care

Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study

Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature

Prevalence, Trend and Disparities of Palliative Care Utilization among Hospitalized Metastatic Breast Cancer Patients Who Received Critical Care Therapies

Evaluating Outcomes for Women with Metastatic Breast Cancer: Palliative Care Consultations, Hospital Charges, and Length of Stay

Hospital-based palliative care referrals: determinants in older adults with cancer

Duration of palliative care before death in international routine practice: a systematic review and meta-analysis

Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization

BE-A-PAL: Behavioral economics and automated analytics to improve palliative care among patients with advanced cancer.

Primary care service use by end-of-life cancer patients: a nationwide retrospective cohort study in the United Kingdom

Palliative and End of Life Care: An Important Component of Supportive Oncology